NICE Recommends Abaloparatide for Osteoporosis ...

By HEOR Staff Writer

September 10, 2024

Introduction The National Institute for Health and Care Excellence (NICE) has recently recommended abaloparatide for treating osteoporosis in postmenopausal women, trans me...
Modifiable Risk Factors for Dementia: Insights from a 15-Year Study
Unlocking the Economic Potential of Healthy Ageing
Enhancing Patient Care in Oncology through Remote Patient Monitoring
Enhancing Osteoarthritis Management Through Health Economics
The Impact of the AI Act on the Healthcare Sector in Europe
A Value Framework for Next-Generation Sequencing in Europe: Access to Precisi...
The Economic Impact of Obesity in Türkiye: A Micro-Costing Analysis
Evaluating AI Systems for Diabetic Retinopathy Screening
ABRE Study: Optimising Treatment for Iliofemoral Venous Obstruction
Psoriasis Treatment and Healthcare Resource Utilisation
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis
The Impact of Immunisation Programmes on Infectious Diseases in Spain